Our services :

We offer the following services for :

Discovery and early screening: Screening on different cancers and lead selection
Preclinical efficacy and lead validation : In-house predictive PDX models enable lead validation
Design and validation of combi-therapies including immunotherapy
Therapy repurposing
Translational biomarker Discovery

We can test all types of drugs (small molecules, targeted therapies, immunotherapy). Our technology allows for :

Creating novel cancer models for preclinical studies
Mimicking clinical trials by comparing therapeutic treatments in parallel on patient tumor replicas
Assessing patient response heterogeneity and identifying biomarkers predictive of therapy efficacy
Assessing tumor aspect, metastasis (localized/metastatic tumor pattern)

EFFICIENT : Up to now, we faced no failure of tumor intake from patient samples, even for cancers for which no mouse model could be obtained, such as prostate PDX models.

ETHIC : Our animal model strictly follows the ethical recommendations and benefits from highly simplified legal obligations.